GL1X · GenesisL1 explorer

MolNFT v1 · #118185 · protein

Crystal structure of extended-spectrum beta-lactamase bel-1 in complex with moxalactam

5EUA: “Crystal structure of extended-spectrum beta-lactamase bel-1 in complex with moxalactam”. X-ray diffraction, 2 ligands (3P7, NA), 4 pockets (best druggability 0.70). MolNFT v1 #118185 on GenesisL1: 3D structure, binding sites and…

PDB
5EUA
Type
protein
Length
513 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
Q3SAW3
Ligands
3P7, NA
Pockets
4 · best druggability 0.70

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein26346% helix, 19% strandQ3SAW3
BBeta-lactamase (EC 3.5.2.6)protein25045% helix, 20% strandQ3SAW3

Ligands and binding sites

  • 3P7 · (2R)-2-[(1R)-1-{[(2R)-2-carboxy-2-(4-hydroxyphenyl)acetyl]amino}-1-methoxy-2-oxoethyl]-5-methylidene-5,6-dihydro-2H-1,3 -oxazine-4-carboxylic acid · ligand · 2 copies · chains A, B
  • NA · Sodium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15530.700.7961empty
2800.400.7918empty
3660.370.7815empty
4650.280.73203P7

Interfaces

1 interface between chains.

  • A–B · 911 Ų buried · 23 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent, 2 disulfide (covalent ligand, disulfide).

Compared structures

  • 5EUA · Crystal structure of extended-spectrum beta-lactamase BEL-1 in complex with Moxalactam · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.